Axtria unveils transformational agentic AI platform for life sciences
Axtria Inc., an AI-first data analytics innovator and global provider of cloud software to the life sciences industry, today announced the launch of Axtria InsightsMAx.ai. The next generation agentic platform reimagines how life sciences organisations harness AI through a flexible enterprise-grade infrastructure that accelerates experimentation, deployment, and ROI.
Axtria InsightsMAx.ai aims to address the critical "last mile" problem in enterprise AI implementation by providing not just the technology, but the entire ecosystem needed for successful adoption.
The platform's library of specialised life sciences agents creates an adaptable framework that breaks down silos between data analysis, business intelligence, commercial operations, and clinical development, enabling cross-functional transformation that drives tangible business outcomes.
Axtria’s head of products, Lokesh Jindal, commented: “Axtria InsightsMAx.ai represents a paradigm shift from incremental AI improvements to true business transformation, [serving] as essential infrastructure […] that makes agentic AI implementation practical, scalable, and measurable.”
Navi Chadha, Axtria’s chief technology officer, added: “What sets our platform apart is its ability to serve as both the experimental sandbox and the production highway for agentic AI. Life sciences companies can start small, proving value in controlled environments, then seamlessly scale successful innovations across their organisation without rebuilding infrastructure.”
One benefit of the next generation Axtria InsightsMAx.ai platform, according to the company, is a compressed “time from concept to enterprise-wide deployment from years to months or even weeks.”
The Axtria InsightsMAx platform.ai offers a complete ecosystem for agentic AI implementation through three interconnected offerings: agents, apps, and APIs. Over 30 domain-specific autonomous agents designed expressly for life sciences workflows are ready for immediate deployment, while pre-built applications with intuitive interfaces will enable business users across an organisation to leverage AI capabilities without technical expertise, and enterprise-grade APIs with pharmaceutical-specific data models and compliance controls enable developers to rapidly build custom solutions while maintaining regulatory compliance.
Built upon Axtria’s 14+ years of pharmaceutical-specific data science expertise and proprietary semantic models, the Axtria InsightsMAx.ai platform is already deployed within six of the top ten global pharmaceutical companies, delivering measurable improved business outcomes, according to the company. Developed in partnership with Genloop, Axtria InsightsMAx.ai features domain-tuned large language models (LLMs) that deliver superior performance with enhanced control and transparency.
Chadha also commented: “The pharmaceutical industry faces unique challenges that generic AI solutions simply cannot address effectively. Our platform combines deep domain knowledge with cutting-edge AI capabilities, creating a purpose-built system that understands the complex interplay of scientific, commercial, and regulatory factors that drive life sciences business transformation.”
Axtria works with 16 of the top 20 life sciences companies globally. The company’s other product offerings also include Axtria SalesIQ, Axtria CustomerIQ, and Axtria MarketingIQ.
